Latest Regeneration Stories
NEW YORK, July 14 /PRNewswire-FirstCall/ -- Sanuwave Health, Inc. (OTC Bulletin Board: SNWV) announces the following Webcast: What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 12:00 PM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=160499 Live over the Internet --Simply log on to the web at the address How: above. Contact: Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com If you are unable...
AUSTIN, Texas, July 1 /PRNewswire/ -- SpineSmith Partners and Celling Technologies hired Brian Burkinshaw as Vice President of Research and Development, strengthening the company's position as an industry leader in adult stem cell technology innovations. Burkinshaw will lead SpineSmith's product development efforts through the collaboration of the company's mechanical engineering department and Celling Technologies' team of scientists. These teams work closely with surgeons to develop...
EAST NORRITON, Pa., June 17 /PRNewswire-FirstCall/ -- Tengion Inc. (Nasdaq: TNGN) today announced that it has presented new preclinical data at the 8th Annual Meeting of the International Society for Stem Cell Research (ISSCR) being held June 16-19 in San Francisco. These data, highlighted during the meeting's poster session on June 16, show the important distinction between adipose-derived smooth muscle cells (SMCs) and mesenchymal stem cells (MSCs). The Tengion data demonstrate that...
ZUG, Switzerland and CANTON, Mass., May 26 /PRNewswire/ -- Organogenesis Switzerland GmbH will sponsor a symposium on Apligraf®, a bilayered living cellular construct for the treatment of chronic wounds and soft tissue repair, at the upcoming European Wound Management Association (EWMA) conference. This will be the first symposium ever held in Europe on the use of an allogeneic living cellular construct in the treatment of chronic wounds. At the symposium, titled "Advanced Living...
EAST NORRITON, Pa., May 26 /PRNewswire-FirstCall/ -- Tengion Inc. (Nasdaq: TNGN) today announced that its scientists have presented new research data in three podium presentations at the 16(th) Annual Meeting of the International Society for Cellular Therapy (ISCT) which was held May 23-26 in Philadelphia. These presentations highlighted key findings in Tengion's Neo-Urinary Conduit and Neo-Kidney Augment programs and provided further information about the company's work with various cell...
Spanish researchers have employed for the first time adult cells extracted from a human heart to turn stem cells from adipose tissue into cardiac myocytes. In other words, they achieved to "reprogram" adult stem cells, which might improve treatments for heart disease therapeutical.At present, the use of stem cells in treatments for heart disease is one of the most common practices. However, working with stem cells without targeting heart tissue negatively affects the efficacy of treatments....
EAST NORRITON, Pa., May 13 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN), a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced it will release its first quarter 2010 financial report before market open on Tuesday, May 18, 2010. Tengion will host a conference call at 9 am Eastern Time in conjunction with the release. Conference Call Access: Date: May 18, 2010...
Scientists at The University of Nottingham have discovered the gene that enables an extraordinary worm to regenerate its own body parts after amputation "” including a whole head and brain.Their research into the Planarian worm is another piece in the scientific jigsaw that could one day make the regeneration of old or damaged human organs and tissues a real possibility.The research led by Dr Aziz Aboobaker, a Research Councils UK Fellow in the School of Biology shows for the first time...
WINSTON-SALEM, N.C., April 9 /PRNewswire-USNewswire/ -- Leaders in the field of regenerative medicine spoke about the potential to transform medicine through new treatments that focus not just on treating disease - but on cures - at the first annual Translational Regenerative Medicine Forum. Attended by more than 400 people from across the world, the event was sponsored by the Regenerative Medicine Foundation. "We are excited to bring together representatives from all facets of this...
A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs) substantially improved efforts to optically track stem cells after transplanting them into heart tissues.The study, carried out by the Departments of Radiology at the University of California and the Technical University of Munich, is freely available on-line at...
